Annual Revenue
$166.66 M
+$10.43 M+6.67%
31 December 2023
Summary:
Anika Therapeutics annual revenue is currently $166.66 million, with the most recent change of +$10.43 million (+6.67%) on 31 December 2023. During the last 3 years, it has risen by +$36.20 million (+27.75%). ANIK annual revenue is now at all-time high.ANIK Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$38.75 M
-$3.17 M-7.56%
30 September 2024
Summary:
Anika Therapeutics quarterly revenue is currently $38.75 million, with the most recent change of -$3.17 million (-7.56%) on 30 September 2024. Over the past year, it has dropped by -$2.71 million (-6.54%). ANIK quarterly revenue is now -12.53% below its all-time high of $44.30 million, reached on 30 June 2023.ANIK Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$164.17 M
-$2.71 M-1.63%
30 September 2024
Summary:
Anika Therapeutics TTM revenue is currently $164.17 million, with the most recent change of -$2.71 million (-1.63%) on 30 September 2024. Over the past year, it has increased by +$855.00 thousand (+0.52%). ANIK TTM revenue is now -3.01% below its all-time high of $169.26 million, reached on 31 March 2024.ANIK TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIK Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.7% | -6.5% | +0.5% |
| 3 y3 years | +27.8% | -2.0% | +13.5% |
| 5 y5 years | +57.9% | +30.5% | +46.9% |
ANIK Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.8% | -12.5% | +8.2% | -3.0% | +13.5% |
| 5 y | 5 years | at high | +57.9% | -12.5% | +30.5% | -3.0% | +46.9% |
| alltime | all time | at high | >+9999.0% | -12.5% | >+9999.0% | -3.0% | >+9999.0% |
Anika Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $38.75 M(-7.6%) | $164.17 M(-1.6%) |
| June 2024 | - | $41.92 M(+3.4%) | $166.88 M(-1.4%) |
| Mar 2024 | - | $40.52 M(-5.7%) | $169.26 M(+1.6%) |
| Dec 2023 | $166.66 M(+6.7%) | $42.97 M(+3.6%) | $166.66 M(+2.1%) |
| Sept 2023 | - | $41.47 M(-6.4%) | $163.31 M(+0.7%) |
| June 2023 | - | $44.30 M(+16.8%) | $162.11 M(+2.9%) |
| Mar 2023 | - | $37.92 M(-4.3%) | $157.47 M(+0.8%) |
| Dec 2022 | $156.24 M(+5.7%) | $39.62 M(-1.6%) | $156.24 M(+2.5%) |
| Sept 2022 | - | $40.26 M(+1.5%) | $152.44 M(+0.5%) |
| June 2022 | - | $39.66 M(+8.1%) | $151.71 M(+1.0%) |
| Mar 2022 | - | $36.69 M(+2.4%) | $150.19 M(+1.6%) |
| Dec 2021 | $147.79 M(+13.3%) | $35.82 M(-9.4%) | $147.79 M(+2.2%) |
| Sept 2021 | - | $39.54 M(+3.6%) | $144.66 M(+5.7%) |
| June 2021 | - | $38.15 M(+11.2%) | $136.82 M(+5.8%) |
| Mar 2021 | - | $34.29 M(+4.9%) | $129.35 M(-0.8%) |
| Dec 2020 | $130.46 M(+13.8%) | $32.69 M(+3.1%) | $130.46 M(+2.3%) |
| Sept 2020 | - | $31.69 M(+3.3%) | $127.54 M(+1.6%) |
| June 2020 | - | $30.68 M(-13.3%) | $125.54 M(+0.2%) |
| Mar 2020 | - | $35.40 M(+18.9%) | $125.28 M(+9.3%) |
| Dec 2019 | $114.61 M(+8.6%) | $29.77 M(+0.3%) | $114.61 M(+2.5%) |
| Sept 2019 | - | $29.70 M(-2.4%) | $111.79 M(+2.7%) |
| June 2019 | - | $30.42 M(+23.0%) | $108.88 M(-0.1%) |
| Mar 2019 | - | $24.72 M(-8.3%) | $109.01 M(+3.3%) |
| Dec 2018 | $105.56 M(-6.9%) | $26.96 M(+0.6%) | $105.56 M(-2.3%) |
| Sept 2018 | - | $26.79 M(-12.3%) | $107.99 M(-0.4%) |
| June 2018 | - | $30.55 M(+43.7%) | $108.38 M(-2.6%) |
| Mar 2018 | - | $21.26 M(-27.6%) | $111.30 M(-1.9%) |
| Dec 2017 | $113.42 M(+9.7%) | $29.39 M(+8.1%) | $113.42 M(+0.6%) |
| Sept 2017 | - | $27.18 M(-18.8%) | $112.76 M(+1.3%) |
| June 2017 | - | $33.46 M(+43.1%) | $111.36 M(+6.6%) |
| Mar 2017 | - | $23.39 M(-18.6%) | $104.48 M(+1.1%) |
| Dec 2016 | $103.38 M(+11.2%) | $28.73 M(+11.4%) | $103.38 M(-2.1%) |
| Sept 2016 | - | $25.79 M(-3.0%) | $105.55 M(+2.0%) |
| June 2016 | - | $26.58 M(+19.3%) | $103.44 M(+3.7%) |
| Mar 2016 | - | $22.28 M(-27.9%) | $99.76 M(+7.3%) |
| Dec 2015 | $93.00 M(-11.9%) | $30.89 M(+30.5%) | $93.00 M(+8.9%) |
| Sept 2015 | - | $23.68 M(+3.4%) | $85.36 M(+1.9%) |
| June 2015 | - | $22.90 M(+47.6%) | $83.73 M(-3.9%) |
| Mar 2015 | - | $15.52 M(-33.3%) | $87.10 M(-17.5%) |
| Dec 2014 | $105.59 M(+40.6%) | $23.25 M(+5.4%) | $105.59 M(+1.9%) |
| Sept 2014 | - | $22.06 M(-16.1%) | $103.59 M(+4.3%) |
| June 2014 | - | $26.27 M(-22.7%) | $99.29 M(+5.8%) |
| Mar 2014 | - | $34.01 M(+60.0%) | $93.84 M(+25.0%) |
| Dec 2013 | $75.08 M(+5.2%) | $21.25 M(+19.7%) | $75.08 M(-1.8%) |
| Sept 2013 | - | $17.75 M(-14.8%) | $76.44 M(+4.1%) |
| June 2013 | - | $20.83 M(+36.6%) | $73.45 M(+1.7%) |
| Mar 2013 | - | $15.25 M(-32.6%) | $72.24 M(+1.2%) |
| Dec 2012 | $71.36 M(+10.2%) | $22.61 M(+53.1%) | $71.36 M(+6.2%) |
| Sept 2012 | - | $14.77 M(-24.8%) | $67.20 M(-5.2%) |
| June 2012 | - | $19.62 M(+36.7%) | $70.89 M(+5.2%) |
| Mar 2012 | - | $14.36 M(-22.1%) | $67.40 M(+4.0%) |
| Dec 2011 | $64.78 M(+16.6%) | $18.44 M(-0.1%) | $64.78 M(+6.1%) |
| Sept 2011 | - | $18.46 M(+14.3%) | $61.06 M(+8.1%) |
| June 2011 | - | $16.14 M(+37.5%) | $56.47 M(+3.0%) |
| Mar 2011 | - | $11.74 M(-20.3%) | $54.83 M(-1.3%) |
| Dec 2010 | $55.56 M(+38.4%) | $14.72 M(+6.1%) | $55.56 M(+8.0%) |
| Sept 2010 | - | $13.87 M(-4.3%) | $51.45 M(+6.4%) |
| June 2010 | - | $14.50 M(+16.3%) | $48.38 M(+11.5%) |
| Mar 2010 | - | $12.47 M(+17.4%) | $43.40 M(+8.1%) |
| Dec 2009 | $40.14 M(+12.2%) | $10.62 M(-1.6%) | $40.14 M(+4.3%) |
| Sept 2009 | - | $10.79 M(+13.3%) | $38.48 M(+4.3%) |
| June 2009 | - | $9.52 M(+3.5%) | $36.89 M(+1.3%) |
| Mar 2009 | - | $9.20 M(+2.6%) | $36.43 M(+1.8%) |
| Dec 2008 | $35.78 M | $8.97 M(-2.6%) | $35.78 M(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2008 | - | $9.21 M(+1.6%) | $36.44 M(+3.5%) |
| June 2008 | - | $9.06 M(+6.0%) | $35.20 M(+5.9%) |
| Mar 2008 | - | $8.55 M(-11.2%) | $33.24 M(+7.8%) |
| Dec 2007 | $30.83 M(+14.9%) | $9.63 M(+20.9%) | $30.83 M(+13.8%) |
| Sept 2007 | - | $7.97 M(+12.2%) | $27.09 M(+7.0%) |
| June 2007 | - | $7.10 M(+15.7%) | $25.33 M(-2.7%) |
| Mar 2007 | - | $6.14 M(+4.2%) | $26.03 M(-3.0%) |
| Dec 2006 | $26.84 M(-10.0%) | $5.89 M(-5.0%) | $26.84 M(+1.6%) |
| Sept 2006 | - | $6.20 M(-20.5%) | $26.42 M(-12.7%) |
| June 2006 | - | $7.80 M(+12.2%) | $30.27 M(+2.6%) |
| Mar 2006 | - | $6.95 M(+27.2%) | $29.50 M(-1.1%) |
| Dec 2005 | $29.83 M(+12.7%) | $5.47 M(-45.7%) | $29.83 M(-6.8%) |
| Sept 2005 | - | $10.06 M(+43.3%) | $32.02 M(+12.9%) |
| June 2005 | - | $7.02 M(-3.7%) | $28.37 M(+2.7%) |
| Mar 2005 | - | $7.29 M(-4.8%) | $27.62 M(+4.3%) |
| Dec 2004 | $26.46 M(+71.8%) | $7.66 M(+19.5%) | $26.46 M(+11.1%) |
| Sept 2004 | - | $6.41 M(+2.3%) | $23.82 M(+12.9%) |
| June 2004 | - | $6.26 M(+2.0%) | $21.11 M(+16.2%) |
| Mar 2004 | - | $6.14 M(+22.5%) | $18.16 M(+17.9%) |
| Dec 2003 | $15.40 M(+16.8%) | $5.01 M(+36.0%) | $15.40 M(+3.7%) |
| Sept 2003 | - | $3.69 M(+11.2%) | $14.86 M(+5.6%) |
| June 2003 | - | $3.32 M(-2.0%) | $14.08 M(-0.7%) |
| Mar 2003 | - | $3.38 M(-24.3%) | $14.18 M(+7.5%) |
| Dec 2002 | $13.19 M(+16.6%) | $4.47 M(+53.9%) | $13.19 M(+11.0%) |
| Sept 2002 | - | $2.90 M(-15.1%) | $11.88 M(-1.2%) |
| June 2002 | - | $3.42 M(+43.2%) | $12.02 M(+4.4%) |
| Mar 2002 | - | $2.39 M(-24.4%) | $11.52 M(+1.9%) |
| Dec 2001 | $11.31 M(-30.8%) | $3.16 M(+3.5%) | $11.31 M(-25.9%) |
| Sept 2001 | - | $3.05 M(+4.6%) | $15.27 M(+2.2%) |
| June 2001 | - | $2.92 M(+34.0%) | $14.94 M(-5.4%) |
| Mar 2001 | - | $2.18 M(-69.4%) | $15.79 M(-3.3%) |
| Dec 2000 | $16.34 M(+18.2%) | $7.12 M(+160.7%) | $16.34 M(+30.2%) |
| Sept 2000 | - | $2.73 M(-27.6%) | $12.54 M(-5.8%) |
| June 2000 | - | $3.77 M(+38.5%) | $13.32 M(+1.8%) |
| Mar 2000 | - | $2.72 M(-18.2%) | $13.08 M(-4.5%) |
| Dec 1999 | $13.83 M(+4.2%) | $3.33 M(-5.0%) | $13.69 M(+4.2%) |
| Sept 1999 | - | $3.50 M(-0.9%) | $13.14 M(+2.3%) |
| June 1999 | - | $3.53 M(+5.9%) | $12.84 M(-7.7%) |
| Mar 1999 | - | $3.34 M(+20.3%) | $13.91 M(+4.0%) |
| Dec 1998 | $13.27 M(+10.6%) | $2.77 M(-13.3%) | $13.37 M(-19.4%) |
| Sept 1998 | - | $3.20 M(-30.4%) | $16.60 M(+10.7%) |
| June 1998 | - | $4.60 M(+64.3%) | $15.00 M(+16.3%) |
| Mar 1998 | - | $2.80 M(-53.3%) | $12.90 M(+7.5%) |
| Dec 1997 | $12.00 M(+900.0%) | $6.00 M(+275.0%) | $12.00 M(+69.0%) |
| Sept 1997 | - | $1.60 M(-36.0%) | $7.10 M(+4.4%) |
| June 1997 | - | $2.50 M(+31.6%) | $6.80 M(+17.2%) |
| Mar 1997 | - | $1.90 M(+72.7%) | $5.80 M(+18.4%) |
| Dec 1996 | $1.20 M(-73.9%) | - | - |
| Nov 1996 | - | $1.10 M(-15.4%) | $4.90 M(+4.3%) |
| Aug 1996 | - | $1.30 M(-13.3%) | $4.70 M(+9.3%) |
| Aug 1996 | $4.60 M(+35.3%) | - | - |
| May 1996 | - | $1.50 M(+50.0%) | $4.30 M(+16.2%) |
| Feb 1996 | - | $1.00 M(+11.1%) | $3.70 M(+8.8%) |
| Nov 1995 | - | $900.00 K(0.0%) | $3.40 M(0.0%) |
| Aug 1995 | $3.40 M(-27.7%) | $900.00 K(0.0%) | $3.40 M(-5.6%) |
| May 1995 | - | $900.00 K(+28.6%) | $3.60 M(-2.7%) |
| Feb 1995 | - | $700.00 K(-22.2%) | $3.70 M(-15.9%) |
| Nov 1994 | - | $900.00 K(-18.2%) | $4.40 M(-6.4%) |
| Aug 1994 | $4.70 M(+113.6%) | $1.10 M(+10.0%) | $4.70 M(-17.5%) |
| May 1994 | - | $1.00 M(-28.6%) | $5.70 M(+18.8%) |
| Feb 1994 | - | $1.40 M(+16.7%) | $4.80 M(+41.2%) |
| Nov 1993 | - | $1.20 M(-42.9%) | $3.40 M(+54.5%) |
| Aug 1993 | $2.20 M | $2.10 M(+2000.0%) | $2.20 M(+2100.0%) |
| May 1993 | - | $100.00 K | $100.00 K |
FAQ
- What is Anika Therapeutics annual revenue?
- What is the all time high annual revenue for Anika Therapeutics?
- What is Anika Therapeutics annual revenue year-on-year change?
- What is Anika Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Anika Therapeutics?
- What is Anika Therapeutics quarterly revenue year-on-year change?
- What is Anika Therapeutics TTM revenue?
- What is the all time high TTM revenue for Anika Therapeutics?
- What is Anika Therapeutics TTM revenue year-on-year change?
What is Anika Therapeutics annual revenue?
The current annual revenue of ANIK is $166.66 M
What is the all time high annual revenue for Anika Therapeutics?
Anika Therapeutics all-time high annual revenue is $166.66 M
What is Anika Therapeutics annual revenue year-on-year change?
Over the past year, ANIK annual revenue has changed by +$10.43 M (+6.67%)
What is Anika Therapeutics quarterly revenue?
The current quarterly revenue of ANIK is $38.75 M
What is the all time high quarterly revenue for Anika Therapeutics?
Anika Therapeutics all-time high quarterly revenue is $44.30 M
What is Anika Therapeutics quarterly revenue year-on-year change?
Over the past year, ANIK quarterly revenue has changed by -$2.71 M (-6.54%)
What is Anika Therapeutics TTM revenue?
The current TTM revenue of ANIK is $164.17 M
What is the all time high TTM revenue for Anika Therapeutics?
Anika Therapeutics all-time high TTM revenue is $169.26 M
What is Anika Therapeutics TTM revenue year-on-year change?
Over the past year, ANIK TTM revenue has changed by +$855.00 K (+0.52%)